Neurology

Ofatumumab sBLA Is Accepted for Treatment of Relapsing Multiple Sclerosis



The novel B-cell therapy has been assigned a PDUFA date of June 2020.

Source link

Related posts

CV Research Spin Abundant in the Era of Alternative Facts

Newsemia

Viktor Frankl on the Power of “Meaning” and the Conception of Psychiatry

Newsemia

Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World